Skip to main content
Fig. 2 | Journal of Pharmaceutical Health Care and Sciences

Fig. 2

From: Effect of blood pressure control on the risk of proteinuria during bevacizumab treatment in patients with colorectal cancer: a single-center retrospective cohort study

Fig. 2

Kaplan-Meier estimates of the cumulative incidence of grade ≥ 2 and severe proteinuria. (a) Grade ≥ 2 proteinuria in normal SBP and high SBP groups (p < 0.001). (b) Severe proteinuria in normal SBP and high SBP groups (p = 0.028). Abbreviations: SBP: systolic blood pressure

Back to article page

Journal of Pharmaceutical Health Care and Sciences

ISSN: 2055-0294

Contact us